Cancer Research 09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 32, 1489-1495, July 1, 1972]
© 1972 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Verbin, R. S.
Right arrow Articles by Farber, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Verbin, R. S.
Right arrow Articles by Farber, E.

Synchronization of Cell Division in Vivo through the Combined Use of Cytosine Arabinoside and Colcemid1

Robert S. Verbin2, Gloria Diluiso, Hilda Liang and Emmanuel Farber

Departments of Pathology, University of Pittsburgh Schools of Medicine and Dental Medicine, Pittsburgh, Pennsylvania 15213 [R. S. V., G. D.], and Fels Research Institute, Temple University, School of Medicine, Philadelphia, Pennsylvania 19140 [H. L., E. F.]

Mitotic activity in Lieberkühn's crypts increased from the 3 to 5% levels normally occurring in 0.9% NaCl solution-injected rats to peak values of 15% in animals treated with a single injection of either ara-C or Colcemid. In animals treated with ara-C followed by Colcemid, 33 to 38% of the crypt epithelial components could be identified as dividing cells, thus indicating a synchronization of at least two-thirds of the proliferating epithelial cells. Of additional significance was the finding that these regimens were not necrogenic to the intestinal epithelium. Further studies utilizing a second injection of Colcemid indicated that synchrony was lost once traversal through the cell cycle was reinstituted.

1 This research was supported in part by Grants CA-11390 and CA-12218 from the National Cancer Institute, Grant AM-14882 from the National Institute of Arthritis and Metabolic Diseases, and Grant BC-7N from the American Cancer Society.

2 Recipient of a Career Development Award (5KO4-DE35155) from the National Institute of Dental Research.

Received 12/22/71. Accepted 3/29/72.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1972 by the American Association for Cancer Research.